Home2575 • HKG
add
Xuanzhu Biopharmaceutical Co Ltd
Previous close
$11.60
Day range
$26.30 - $31.00
Year range
$26.30 - $31.00
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
In the news
Financials
Income Statement
Revenue
Net income
| (CNY) | 2021info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 416.96M | 74.69% |
Net income | -461.58M | -184.13% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -398.82M | -78.67% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | 2021info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.23B | 28.74% |
Total assets | 1.87B | 31.87% |
Total liabilities | 91.22M | 35.59% |
Total equity | 1.78B | — |
Shares outstanding | 450.61M | — |
Price to book | 2.94 | — |
Return on assets | -15.84% | — |
Return on capital | -16.48% | — |
Cash Flow
Net change in cash
| (CNY) | 2021info | Y/Y change |
|---|---|---|
Net income | -461.58M | -184.13% |
Cash from operations | -411.43M | -98.14% |
Cash from investing | 48.77M | 127.91% |
Cash from financing | 857.69M | -6.21% |
Net change in cash | 495.01M | -6.98% |
Free cash flow | -336.77M | -96.36% |
About
Founded
2008
Website
Employees
197
